Page last updated: 2024-12-08
3-methylitaconate
Description
3-methylitaconate: RN refers to (S)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 6438940 |
CHEMBL ID | 4761396 |
SCHEMBL ID | 6365923 |
MeSH ID | M0139839 |
Synonyms (8)
Synonym |
3-methylitaconate |
AKOS006374421 |
(2e)-2-ethylidenebutanedioic acid |
102714-66-9 |
SCHEMBL6365923 |
CHEMBL4761396 |
DTXSID201347631 |
(e)-ethylidenesuccinic acid |
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
AID1685613 | Covalent inhibition of wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) using DL-isocitrate as substrate measured after 1 hr by UV-Vis spectrophotometric analysis | 2021 | RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
| Itaconate is a covalent inhibitor of the |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |